vimarsana.com

Page 42 - பல்கலைக்கழகம் ஆஃப் சிகாகோ மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SBRT Safe for Cancer Patients With Multiple Metastases

email article Stereotactic body radiotherapy (SBRT) proved safe for treating cancer patients with multiple metastases, according to a phase I trial. In the NRG-BR001 trial, standard doses of SBRT were safe in 35 patients with oligometastatic breast, prostate, and non-small cell lung cancer (NSCLC) with a median of three or four metastases, or two within proximity to each other, reported Steve Chmura, MD, PhD, of University of Chicago Medicine, and colleagues. Also, there were no protocol-defined dose-limiting toxicities in these patients at 180 days after the initiation of therapy, they stated in However, the authors noted that a number of patients experienced late grade 3 adverse events (AEs), most likely related to the protocol therapy, which demonstrated the need for long-term follow-up with these patients.

Chicago hospital finds only temporary spike in hand-washing during pandemic temporary • Hospitals continue to see narrow operating margins • Allscripts revenue declines

Getty Images CHICAGO HOSPITAL STUDIES HAND HYGIENE COMPLIANCE: Hand hygiene among University of Chicago Medical Center workers improved early in the pandemic before dropping to pre-COVID levels after just four months, according to a new study in JAMA Internal Medicine. Researchers examined hand hygiene compliance in the Hyde Park hospital by day, week and month from September 2019 through August 2020, during which time UCMC admitted 1,159 COVID-positive patients. They also looked specifically at compliance among the hospital’s temporary COVID units. Hand hygiene compliance reached a weekly peak of 88 percent across all units and 98 percent across COVID units during the week of March 29, 2020, the study shows. Meanwhile, compliance declined across all units to a daily low of 51 percent on August 15, and a weekly low of 55 percent that same week.

Faith, fitness and innovation help UChicago patient beat COVID-19

As more people skip 2nd dose, health experts warn about possible resurgence

As more people skip 2nd dose, health experts warn about possible resurgence and last updated 2021-04-30 14:13:49-04 CHICAGO, Ill. — The Centers for Disease Control and Prevention (CDC) revealed this week that an estimated 5 million people got their first COVID-19 vaccine dose, but missed or skipped their second. That means they may not be fully vaccinated against the virus. Daniel Morroni and his wife, who is immunocompromised, both contracted COVID-19 back in November. “We had body aches, back pain, night sweats, chills, fever. We had everything,” said the 58-year-old man. So, when they became eligible for the vaccine – the couple made sure to get their first shot. But two weeks away from a second dose, Morroni and his wife are unsure about the second.

Data Doctor In The House – CIO East Africa

With patient data spanning numerous diagnostic and care systems, greater data alignment and sharing can provide the complete picture of the patient that doctors require. This can accelerate diagnosis and treatment while yielding healthier outcomes. By getting better access to and insights from their data, providers can personalise patient care. This more focused approach saves time and money while putting people first. Furthermore, data analytics can be used to prepare for future healthcare scenarios, an increasingly important option for emerging countries like ourselves. Predicting healthcare analytics Advertisement By combining patient care and historical data, hospitals can leverage technology to develop a predictive model in a real-time environment. This enables faster and accurate decision-making and can become invaluable for the healthcare industry as financial and pandemic-related pressures continue to mount.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.